Diagnosed with Cancer? Your two greatest challenges are understanding cancer and understanding possible side effects from chemo and radiation. Knowledge is Power!
Learn about conventional, complementary, and integrative therapies.
Dealing with treatment side effects? Learn about evidence-based therapies to alleviate your symptoms.
Click the orange button to the right to learn more.
Pre-Myeloma Articles
Articles That Discuss Pre-Myeloma
SMM or MM- What’s the difference?
Multiple myeloma is defined as smoldering (asymptomatic) or active (symptomatic). The NCCN criteria for smoldering multiple myeloma are as follows The presence of any of the CRAB criteria or any of
Continue readingMGUS- Evidence-Based, Non-Toxic Therapies
Don’t Want to “Watch and Wait?” Reduce Your Risks of Multiple Myeloma, Lose a Few Pounds, Get Healthy and Feel Great- A diagnosis of monoclonal gammopathy of undetermined significance
Continue readingIs “Plasma Cell Dyscrasia” a Diagnosis of MGUS, SMM or MM?
“Plasma cell dyscrasias (MGUS, SMM, MM) are a heterogeneous group of disorders caused by the monoclonal proliferation of lymphoplasmacytic cells in the bone marrow. Multiple myeloma is the most
Continue readingWait for Pre-Myeloma to Progress or Try Non-Conventional Therapies?
Now we have to wonder how long the lesion (pre-myeloma) will sit there. We can’t pretend they’re not there, but we don’t know what they mean. A single plasmacytoma (SBP), monoclonal gammopathy of
Continue readingCoffee- Manage Pre-Myeloma, SBP, MGUS, SMM
The studies below document coffee’s heart and brain health promoting, anti-stroke, anti-diabetic, and all around ability to reduce risk of death. I’m a long-term multiple myeloma survivor
Continue readingPre-Myeloma- Pesticides, Virus’, Environment?
“Among study participants older than 50 years, 38 were found to have MGUS, (pre-myeloma) yielding a prevalence of 6.8% What caused my pre-myeloma (MGUS, SMM, MM) is the first question many of us
Continue readingSolitary Plasmacytoma- In Bone, Outside of Bone?
Solitary plasmacytomas most frequently occur in bone (plasmacytoma of bone), but can also be found outside bone in soft tissues (extramedullary plasmacytoma) . The diagnosis and management of SPB will
Continue readingSMM Progression- M-spike and FLC are key-
Several prediction models for SMM progression to MM have been proposed and are typically based on a combination of biomarkers at diagnosis, such as level of MP, BMPCs, and FLCr. Hi David- I have been
Continue readingSlow/Stop SMM’s March Toward Full-Blown Multiple Myeloma
“Hyperdiploid-myeloma is associated with male sex, kappa immunoglobulin subtype, symptomatic bone disease and better survival compared to nonhyperdiploid-MM Hi David-I contacted you a couple months
Continue readingSmoldering Myeloma, TTP, Risk, Non-toxic Treatment
“…though they said their model was not able to accurately discriminate between patients with one or two risk factors during the first 2 to 3 years…” Let’s be clear. A risk
Continue readingMGUS- Risk of Blood Clots
Monoclonal Gammopathy of Undetermined Significance- Asymptomatic, Pre-Myeloma Blood Disorder that can Increase Susceptibility to Deep Vein Thrombosis aka Blood Clots Have you been diagnosed with Monoclonal
Continue readingMGUS & AutoImmune Disease
A history of autoimmune disease was associated with a reduced risk of progression from MGUS to MM… yet prior autoimmune disease increases the risk of a diagnosis of multiple myeloma… Talk
Continue reading